Advanced Solid Tumors

Showing NaN - NaN of 58

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Solid Tumors Trial in Canada, United States (LCB84, Anti-PD-1 mAb)

Not yet recruiting
  • Advanced Solid Tumors
  • LCB84
  • Anti-PD-1 monoclonal antibody
  • Los Angeles, California
  • +6 more
Jul 4, 2023

Advanced Solid Tumors Trial in United States (REGN7075, cemiplimab)

Recruiting
  • Advanced Solid Tumors
  • San Francisco, California
  • +9 more
Jan 30, 2023

Advanced Cancer, Anal Carcinoma, Anal Cancer Trial in Worldwide (pembrolizumab)

Recruiting
  • Advanced Cancer
  • +24 more
  • pembrolizumab
  • Los Angeles, California
  • +21 more
Jan 18, 2023

Metastatic Castration-Resistant Prostate Cancer, Metastatic Breast Cancer, NSCLC Trial in Worldwide (CCS1477, Abiraterone

Recruiting
  • Metastatic Castration-Resistant Prostate Cancer
  • +3 more
  • Boston, Massachusetts
  • +21 more
Jan 10, 2023

Advanced Solid Tumors Trial in Canada, United States (BMS-986408, Nivolumab, Ipilimumab)

Recruiting
  • Advanced Solid Tumors
  • Boston, Massachusetts
  • +5 more
Jan 10, 2023

NSCLC, Colorectal Cancer, Advanced Solid Tumors Trial in Worldwide (GDC-6036, Atezolizumab, Cetuximab)

Recruiting
  • Non-Small Cell Lung Cancer
  • +2 more
  • Duarte, California
  • +68 more
Jan 10, 2023

Advanced Solid Tumors Trial in Worldwide (Elimusertib (BAY1895344), Pembrolizumab)

Active, not recruiting
  • Advanced Solid Tumors
  • Palo Alto, California
  • +15 more
Jan 6, 2023

NSCLC (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC) Trial in United States (RMC-6236)

Recruiting
  • Non-small Cell Lung Cancer (NSCLC)
  • +3 more
  • Boston, Massachusetts
  • +9 more
Dec 22, 2022

Advanced Solid Tumors Trial in Worldwide (ALKS 4230, ALKS 4230 + pembrolizumab)

Active, not recruiting
  • Advanced Solid Tumors
  • ALKS 4230
  • ALKS 4230 + pembrolizumab
  • Denver, Colorado
  • +30 more
Nov 23, 2022

Advanced Solid Tumors, HER2-positive Breast Cancer Trial in United States (ZN-A-1041 50mg BID, ZN-A-1041 100mg BID, ZN-A-1041

Recruiting
  • Advanced Solid Tumors
  • HER2-positive Breast Cancer
  • ZN-A-1041 50mg BID
  • +12 more
  • Tucson, Arizona
  • +6 more
Nov 16, 2022

Advanced Solid Tumors Trial in Worldwide (INCB081776, INCMGA00012)

Recruiting
  • Advanced Solid Tumors
  • New Haven, Connecticut
  • +19 more
Nov 10, 2022

Advanced Malignancy, Advanced Solid Tumors, Cancer Trial in United States (AMG 337)

Completed
  • Advanced Malignancy
  • +5 more
  • AMG 337
  • Los Angeles, California
  • +7 more
Nov 3, 2022

Lymphoma, Advanced Solid Tumors Trial in Worldwide (E7766)

Completed
  • Lymphoma
  • Advanced Solid Tumors
  • New Haven, Connecticut
  • +12 more
Oct 21, 2022

Advanced Solid Tumors Trial in United States (FF-10850 Topotecan Liposome Injection)

Recruiting
  • Advanced Solid Tumors
  • FF-10850 Topotecan Liposome Injection
  • Scottsdale, Arizona
  • +5 more
Oct 19, 2022

Advanced Solid Tumors Trial in Japan, United States (DS-8201a (DP1), DS-8201a (DP2), DS-8201a (DP))

Active, not recruiting
  • Advanced Solid Tumors
  • DS-8201a (DP1)
  • +2 more
  • San Diego, California
  • +13 more
Oct 4, 2022

Advanced Solid Tumors Trial in United States (mRNA-4359, Pembrolizumab)

Recruiting
  • Advanced Solid Tumors
  • mRNA-4359
  • Pembrolizumab
  • San Francisco, California
  • +9 more
Sep 7, 2022

Advanced Solid Tumors Trial in United States (ARRY-382, Pembrolizumab)

Terminated
  • Advanced Solid Tumors
  • Los Angeles, California
  • +29 more
May 21, 2022

Advanced Solid Tumors Trial in United States (KSQ-4279, KSQ-4279 will be combined in separate cohorts, including combination

Recruiting
  • Advanced Solid Tumors
  • KSQ-4279
  • KSQ-4279 will be combined in separate cohorts, including combination with an oral PARPi (poly adenosine diphosphate-ribose polymerase inhibitor)
  • Boston, Massachusetts
  • +4 more
Apr 5, 2022

Advanced Solid Tumors, Sarcoma Trial in United States (TP-1287)

Recruiting
  • Advanced Solid Tumors
  • Sarcoma
  • Los Angeles, California
  • +9 more
Apr 4, 2022

Advanced Solid Tumors Trial in United States (TP-0184)

Completed
  • Advanced Solid Tumors
  • Scottsdale, Arizona
  • +4 more
Apr 4, 2022

Advanced Solid Tumors, Head Neck Cancer, Pancreatic Cancer Trial in United States (Cabiralizumab, Nivolumab)

Completed
  • Advanced Solid Tumors
  • +6 more
  • Cabiralizumab
  • Nivolumab
  • Scottsdale, Arizona
  • +38 more
Jan 5, 2022

Advanced Solid Tumors Trial in Worldwide (Intervention)

Completed
  • Advanced Solid Tumors
  • Intervention
  • Birmingham, Alabama
  • +48 more
Jan 18, 2022

Advanced Solid Tumors Trial in Boston (sapacitabine and seliciclib)

Completed
  • Advanced Solid Tumors
  • sapacitabine and seliciclib
  • Boston, Massachusetts
  • +1 more
Dec 7, 2021